Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12378231
Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof
granted -
US 12378245
Crystalline forms of an RSK inhibitor
granted -
US 12378241
Pyridine derivative as FGFR and VEGFR dual inhibitors
granted -
US 12377078
Viral inhibitors, the synthesis thereof, and intermediates thereto
granted -
CN 120418289
Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors
granted -
US 12371434
MLL1 inhibitors and anti-cancer agents
granted -
US 12370194
Metalloenzyme inhibitor compounds
granted -
US 12370195
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted -
US 12364688
NSD family inhibitors and methods of treatment therewith
granted -
US 12365664
Small molecule inhibitors of SRC tyrosine kinase
granted -
US 12365688
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
granted -
US 12365653
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 12365659
Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancers
granted -
US 12357650
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
granted -
US 12358896
LRRK2 inhibitors and methods of making and using thereof
granted -
US 12358931
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
granted -
US 12358892
Metalloenzyme inhibitors for treating cancers, Alzheimer's disease, hemochromatosis, and other disorders
granted -
US 12351587
Bicyclic compound as RIP-1 kinase inhibitor and application thereof
granted -
US 12343380
Expansion of TILs utilizing AKT pathways inhibitors
granted -
US 12344585
Crystalline salts of a plasma kallikrein inhibitor
granted -
US 12336976
Glutaminase inhibitor therapy
granted -
US 12338242
TYK2 inhibitors and uses thereof
granted -
US 12331058
SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same
granted